Patients With Any Advanced Solid Tumors

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB09079Nintedanib1Recruiting1
DB09037Pembrolizumab1Recruiting1